Antimicrobial resistance is exponentially worsening, and the spread of prevalent carbapenem resistant Enterobacteriaceae (CRE) is a major contributor to this global concern. Infection prevention and control strategies are increasingly consolidated key tools to control this worldwide problem.
Aim
To identify, collect and analyse available evidence regarding the impact of infection prevention and control strategies on prevalent CRE dissemination.
Methods
Pubmed®, Scopus® and Web of Science® were searched systematically for articles published between 1th January 2017 and 30th June 2020, guided by the research question ‘What are the most effective and efficient strategies to prevent and control infection/colonisation caused by Carbapenem resistant Escherichia coli and Carbapenem resistant Klebsiella pneumoniae?’.
Findings
Eleven thousand six hundred and thirty-five publications were found, but after applying the inclusion and exclusion criteria, only 30 were selected. The majority of reviewed studies (n = 24) were performed in outbreak situations, 26 studies occurred in acute care units and of those, 17 in intensive care units . From the set of implemented infection prevention and control measures, in 29 studies surveillance cultures were applied, in 23 studies patients were isolated or cohorted and, in general, all described the implementation of standard and contact precaution measures.
Conclusion
This systematic review underlines the importance of infection prevention and control strategies in CRE dissemination, standing out the need of further studies outside outbreak and intensive care units contexts. Investment increments and training and educating of all involved are also important contributors to shift this problem, but still with relevant gaps in their implementation, in all types of care units, that need to be addressed.
AhnKHwangGYKimYK, et al. (2019) Nosocomial outbreak caused by NDM-5 and OXA-181 carbapenemase co-producing Escherichia coli. Infection & Chemotherapy51(2): 177–182. DOI: 10.3947/ic.2019.51.2.177.
2.
BarrattRBrownLO’CallaghanM (2017) A challenging outbreak of new delhi metallo-β-lactamase-5 producing klebsiella pneumoniae in a new zealand tertiary hospital: a case report. Infection, Disease & Health22(3): 144–149. DOI: 10.1016/j.idh.2017.05.001.
3.
BattikhHHarchayCDekhiliA, et al. (2017) Clonal spread of colistin-resistantklebsiella pneumoniaecoproducing kpc and vim carbapenemases in neonates at a tunisian university hospital. Microbial Drug Resistance: Mdr: Mechanisms, Epidemiology, and Disease23(00): 468–472. DOI: 10.1089/mdr.2016.0175.
4.
Bocanegra-IbariasPGarza-GonzálezEPadilla-OrozcoM, et al. (2019) The successful containment of a hospital outbreak caused by NDM-1-producing klebsiella pneumoniae ST307 using active surveillance. Plos One14(2): e0209609. DOI: 10.1371/journal.pone.0209609.
5.
BorgmannSPfeiferYBeckerL, et al. (2018) Findings from an outbreak of carbapenem-resistant klebsiella pneumoniae emphasize the role of antibiotic treatment for cross transmission. Infection46(1): 103–112. DOI: 10.1007/s15010-017-1103-3.
6.
BrkicDVPristasICiprisI, et al. (2017) Successful containment of the first KPC-producing klebsiella pneumoniae outbreak in croatia. Future Microbiology12: 967–974. DOI: 10.2217/fmb-2016-0143.
7.
BruinsMJKoning ter HeegeAHvan den Bos-KromhoutMI, et al. (2020) VIM-carbapenemase-producing Escherichia coli in a residential care home in The Netherlands. Journal of Hospital Infection104(1): 20–26. DOI: 10.1016/j.jhin.2019.08.012.
8.
CastagnolaETatarelliPMesiniA, et al. (2019) Epidemiology of carbapenemase-producing enterobacteriaceae in a pediatric hospital in a country with high endemicity. Journal of Infection and Public Health12(2): 270–274. DOI: 10.1016/j.jiph.2018.11.003.
9.
ChenCZhangYYuSL, et al. (2019) Tracking carbapenem-producing klebsiella pneumoniae outbreak in an intensive care unit by whole genome sequencing. Frontiers in Cellular and Infection Microbiology9: 281. DOI: 10.3389/fcimb.2019.00281.
10.
Cienfuegos-GalletAVOcampo de Los RíosAMSierra VianaP, et al. (2019) Risk factors and survival of patients infected with carbapenem-resistant klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study. BMC Infectious Diseases19(1): 1–13. DOI: 10.1186/s12879-019-4461-x.
DecraeneVPhanHTTGeorgeR, et al. (2018) A large, refractory nosocomial outbreak of klebsiella pneumoniae carbapenemase-producing Escherichia coli demonstrates carbapenemase gene outbreaks involving sink sites require novel approaches to infection control. Antimicrobial Agents and Chemotherapy62(12): 1–12. DOI: 10.1128/AAC.01689-18.
13.
DoronSDavidsonLE (2011) Antimicrobial stewardship. Mayo Clinic Proceedings86(11): 1113–1123. DOI: 10.4065/mcp.2011.0358.
14.
DumanYErsoyYGursoyNC, et al. (2020) A silent outbreak due to Klebsiella pneumoniae that co-produced NDM-1 and OXA-48 carbapenemases, and infection control measures. Iranian Journal of Basic Medical Sciences23: 46–60. doi: 10.22038/IJBMS.2019.35269.8400.
15.
Durante-MangoniEAndiniRZampinoR (2019) Management of carbapenem-resistant Enterobacteriaceae infections. Clinical Microbiology and Infection25: 943–950. DOI: 10.1016/j.cmi.2019.04.013.
16.
EceGTuncEOtluB, et al. (2018) Detection of blaOXA-48 and clonal relationship in carbapenem resistant K. pneumoniae isolates at a tertiary care center in western turkey. Journal of Infection and Public Health11(5): 640–642. DOI: 10.1016/j.jiph.2018.04.003.
17.
European Centre for Disease Prevention and Control (2019) Surveillance of Antimicrobial Resistance in Europe 2018. Stockholm: European Centre for Disease Prevention and Control.
18.
FerrariCCorbellaMGaiarsaS, et al. (2019) Multiple klebsiella pneumoniae KPC clones contribute to an extended hospital outbreak. Frontiers in Microbiology10: 1–11. DOI: 10.3389/fmicb.2019.02767.
19.
García-ArenzanaNRedondo-BravoLEspinel-RuizMA, et al. (2020) Carbapenem-resistant enterobacteriaceae outbreak in a medical ward in spain: epidemiology, control strategy, and importance of environmental disinfection. Microbial Drug Resistance26(1): 54–59. DOI: 10.1089/mdr.2018.0390.
20.
GorgulhoAGriloAMde FigueiredoM, et al. (2020) Carbapenemase-producing enterobacteriaceae in a portuguese hospital - a five-year retrospective study. Germs10(2): 95–103. DOI: 10.18683/germs.2020.1190.
21.
GuDDongNZhengZ, et al. (2018) A fatal outbreak of ST11 carbapenem-resistant hypervirulent klebsiella pneumoniae in a chinese hospital: a molecular epidemiological study the lancet infectious diseases. The Lancet Infectious Diseases18(1): 37–46. DOI: 10.1016/S1473-3099(17)30489-9.
22.
Hernández-GarcíaMPérez-VisoBLeón-SampedroR, et al. (2019) Outbreak of NDM-1+CTX-M-15+DHA-1-producing klebsiella pneumoniae high-risk clone in spain owing to an undetectable colonised patient from pakistan. International Journal of Antimicrobial Agents54(2): 233–239. DOI: 10.1016/j.ijantimicag.2019.05.021.
23.
HigginsJPTAltmanDGGotzschePC, et al. (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. Bmj: British Medical Journal343: d5928. DOI: 10.1136/bmj.d5928.
24.
HolmesAHMooreLSPSundsfjordA, et al. (2016) Understanding the mechanisms and drivers of antimicrobial resistance. Lancet387(10014): 176–187. DOI: 10.1016/S0140-6736(15)00473-0.
25.
KongZCaiRChengC, et al. (2019) First reported nosocomial outbreak of NDM-5-producing klebsiella pneumoniae in a neonatal unit in china. Infection and Drug Resistance12: 3557–3566. DOI: 10.2147/IDR.S218945.
26.
LegeayCThépot-SeegersVPailhorièsH, et al. (2018) Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? a single-centrexperience. Journal of Hospital Infection99(4): 390–395. DOI: 10.1016/j.jhin.2018.02.003.
27.
LiMWangXWangJ, et al. (2019) Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: a 4-year quasi-experimental before-and-after study. Antimicrobial Resistance & Infection Control8(1): 1–10. DOI: 10.1186/s13756-018-0453-7.
MadueñoAGonzález GarcíaJFernández-RomeroS, et al. (2017) Dissemination and clinical implications of multidrug-resistant Klebsiella pneumoniae isolates producing OXA-48 in a spanish hospital. Journal of Hospital Infection96: 116–122. DOI: 10.1016/j.jhin.2017.02.024.
30.
MagiorakosAPBurnsKRodríguez BañoJ, et al. (2017) Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the european centre for disease prevention and control. Antimicrobial Resistance & Infection Control6(113): 1–17. DOI: 10.1186/s13756-017-0259-z.
31.
ManningMLSeptimusEJAshleyESD, et al. (2018) Antimicrobial stewardship and infection prevention-leveraging the synergy: a position paper update. American Journal of Infection Control46(4): 364–368. DOI: 10.1016/j.ajic.2018.01.001.
32.
MartinJPhanHTTFindlayJ, et al. (2017) Covert dissemination of carbapenemase-producing klebsiella pneumoniae (KPC) in a successfully controlled outbreak: long- and short-read whole-genome sequencing demonstrate multiple genetic modes of transmission. Journal of Antimicrobial Chemotherapy72(11): 3025–3034. DOI: 10.1093/jac/dkx264.
33.
MillsJPTalatiNJAlbyK, et al. (2016) The epidemiology of carbapenem-resistant klebsiella pneumoniae colonization and infection among long-term acute care hospital residents. Infection Control & Hospital Epidemiology37(1): 55–60. DOI: 10.1017/ice.2015.254.
O’NeillJ (2014) ‘Antimicrobial resistance: tackling a crisis for the health and wealth of nations’. Review On Antimicrobial ResistanceTackling a crisis for the health and wealth of nations_1.pdf. London, 1–20. Available at:https://amr-review.org/sites/default/files/AMRReview Paper - Tackling a crisis for the health and wealth of nations_1.pdf.
Organisation for Economic Co-operation and Development (OECD) (2018) Stemming the superbug tide - just a few dollars more. Paris: OECD Publishing. DOI: 10.1787/9789264307599-en.
39.
PiršMCerar KišekTKrižan HergouthV, et al. (2019) Successful control of the first OXA-48 and/or NDM carbapenemase-producing Klebsiella pneumoniae outbreak in slovenia 2014-2016. Journal of Hospital Infection101(2): 142–149. DOI: 10.1016/j.jhin.2018.10.022.
40.
ProtonotariouEPoulouAPolitiL, et al. (2018) ‘Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in northern greece ⋆’, International Journal of Antimicrobial Agents52(3): 331–337. DOI: 10.1016/j.ijantimicag.2018.04.004.
RileyDSBarberMSKienleGS, et al. (2017) CARE guidelines for case reports: explanation and elaboration document. Journal of Clinical Epidemiology89: 218–235. DOI: 10.1016/j.jclinepi.2017.04.026.
43.
ShamseerLMoherDClarkeM, et al. (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Bmj: British Medical Journal349: g7647. DOI: 10.1136/bmj.g7647.
44.
SmoldersDHendriksBRogiersP, et al. (2019) Acetic acid as a decontamination method for ICU sink drains colonized by carbapenemase-producing nterobacteriaceae and its effect on CPE infections. Journal of Hospital Infection102(1): 82–88. DOI: 10.1016/j.jhin.2018.12.009.
45.
SpencerMDWingleeKPassarettiC, et al. (2019) Whole genome sequencing detects inter-facility transmission of carbapenem-resistant klebsiella pneumoniae. Journal of Infection78(3): 187–199. DOI: 10.1016/j.jinf.2018.11.003.
46.
StoneSPCooperBSKibblerCC, et al. (2007) The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Journal of Antimicrobial Chemotherapy59(5): 833–840. DOI: 10.1093/jac/dkm055.
47.
StrichJRPalmoreTN (2017) Preventing transmission of multidrug-resistant pathogens in the intensive care unit. Infectious Disease Clinics of North America31(3): 535–550. DOI: 10.1016/j.idc.2017.05.010.
48.
TomczykSZanichelliVGraysonML, et al. (2019) Control of carbapenem-resistant enterobacteriaceae, acinetobacter baumannii, and pseudomonas aeruginosa in healthcare facilities: a systematic review and reanalysis of quasi-experimental studies. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America68(5): 873–884. DOI: 10.1093/cid/ciy752.
49.
TrepanierPMallardKMeunierD, et al. (2017) Carbapenemase-producing enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures. Journal of Antimicrobial Chemotherapy72(2): 596–603. DOI: 10.1093/jac/dkw414.
50.
VockITschudin-SutterS (2019) Carbapenem-resistant Klebsiella pneumoniae-impact of infection-prevention and control interventions. Annals of Translational Medicine7(S8): S344. DOI: 10.21037/atm.2019.09.91.
51.
WangHWangHYuX, et al. (2019) Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a chinese hospital, 2010-2016: a retrospective observational study. BMC Ophthalmology9(8): e026072–e026079. DOI: 10.1136/bmjopen-2018-026072.
52.
WeberSGHuangSSOriolaS, et al. (2007) Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci: position statement from the joint SHEA and APIC task force. American Journal of Infection Control35(2): 73–85. DOI: 10.1016/j.ajic.2007.01.001.
53.
WilmontSHesselsAJKellyAM, et al. (2018) Family experiences and perspectives on infection prevention in pediatric long-term care. Rehabilitation Nursing43(6): 307–314. DOI: 10.1097/rnj.0000000000000013.
54.
World Health Organization (2009) WHO Guidelines on Hand Hygiene in Health Care - First Global Patient Safety Challenge Clean Care is Safer Care. Geneva. Available at:https://apps.who.int/iris/bitstream/handle/10665/44102/9789241597906_eng.pdf;jsessionid=5F9706052AE6A9AE5B56A1FD746A19D6?sequence=1. (accessed 3 February 2019).
55.
World Health Organization (2016a) Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level. Geneva. Available at:http://apps.who.int/bookorders (accessed 23 January 2019).
World Health Organization (2019) Implementation Manual to Prevent and Control the Spread of Carbapenem-Resistant Organisms at the National and Health Care Facility Level. Geneva, 98. Available at:http://apps.who.int/iris.
58.
YanZZhouYDuM, et al. (2019) Prospective investigation of carbapenem-resistant Klebsiella pneumonia transmission among the staff, environment and patients in five major intensive care units, Beijing. Journal of Hospital Infection101(2): 150–157. DOI: 10.1016/j.jhin.2018.11.019.
59.
YinLHeLMiaoJ, et al. (2020) Active surveillance and appropriate patient placement in contact isolation dramatically decreased carbapenem-resistant Enterobacterales infection and colonization in paediatric patients in china. Journal of Hospital Infection105(3): 486–494. DOI: 10.1016/j.jhin.2020.03.031.
60.
ZinggWStorrJParkBJ, et al. (2019) Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3). Antimicrobial Resist Infect Control8(74): 1–5. DOI: 10.1186/s13756-019-0528-0.
